Marksans PharmaMARKSANS 
$2.71-1.45%24h
-1.45%24h
Global rank7078
Market cap$1.12B
Change 7d7.77%
YTD Performance39.53%
SP500 benchmarkOutperform
P/E0.42
P/S5.09
Revenue$220.68M
Earnings$31.66M
Dividend yield-
Main Sector
Healthcare
Category
EPS for Marksans Pharma (MARKSANS)
Marksans Pharma has an EPS of $6.41. In 2022, the company made an earnings per share (EPS) of $4.51. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for MARKSANS
-
Value:-
EPS history for Marksans Pharma from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | $6.41 | 42.13% |
| 2022 | $4.51 | -22.61% |
| 2021 | $5.83 | 97.54% |
| 2020 | $2.95 | - |
View the highest EPS stocks
